Page 57 - Practice Guidelines News Today

New NCCN Guidelines Analyze Evidence for Cancer Type Found Almost Exclusively in Children USA - English Share this article Share this article National Comprehensive Cancer Network publishes first-ever complete medical guidelines for a pediatric solid tumor, so children everywhere receive the best care based on the latest research. NCCN Guidelines for Wilms Tumor shares information for earlier, safer diagnosis and treatment in effort to reduce disparities; doctors warn of late diagnosis as a pos...

Unexpected Findings on Weight Loss and Breast Cancer from International Study in JNCCN New research found that weight loss after diagnosis was associated with worse outcomes for HER2-positive early breast cancer patients News provided by Share this article PLYMOUTH MEETING, Pa., Feb. 16, 2021 /PRNewswire/ -- New research in the February 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network examined body mass index (BMI) data for people with HER2-positive early breast canc...

Selfie-taking tourists could be spreading Covid-19 to gorillas CNN 2/18/2021 © Andrew Walmsley An adult mountain gorilla pictured in Volcanoes National Park, Rwanda. Tourists who take selfies with wild mountain gorillas could put the primates at risk of developing Covid-19, according to new research. Scientists from Oxford Brookes University, England, looked at hundreds of Instagram posts from people visiting the animals in East Africa and found most tourists were close enough to gorillas ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Poxel Reports Financial Update for Cash and Revenue for the Full Year 2020 and Provides Corporate Update February 12, 2021 GMT LYON, France--(BUSINESS WIRE)--Feb 12, 2021-- POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced ...

Median overall survival of 24.6 months in previously treated checkpoint inhibitor naïve non-small cell lung cancer patients who received HS-110 in combination with nivolumab DURHAM, NC / ACCESSWIRE /

Date Time Elderly esophageal cancer patients often receive suboptimal therapy due to perceived risks Older patients who do receive recommended multimodal therapy, including surgery, have outcomes comparable with those of younger patients CHICAGO: Elderly patients (70 years and over) with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer (located in the stomach and esophagus) should be considered for optimal therapy that has the potential to cure. This therapy regimen inc...

Patrick Delaney Named New Executive Director of NCCN Foundation Incoming leader to oversee fundraising to share trustworthy information about cancer for patients and caregivers as well as supporting promising early-career cancer researchers. News provided by Share this article ®. Delaney has previously held leadership roles with the Juvenile Diabetes Research Foundation, American Red Cross, and American Cancer Society. His new position with NCCN will involve fundraising for the NCCN Guidelines...

Share this article Share this article RARITAN, N.J., Feb. 8, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the final analysis of the Phase 3 TITAN study, which demonstrated the continued statistically significant benefit of the addition of ERLEADA ® (apalutamide) to androgen deprivation therapy (ADT) in overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC), regardless of extent of disease, w...

Share this article Share this article RARITAN, N.J., Feb. 8, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized, double-blind, placebo-controlled Phase 3 ACIS study, which met the primary endpoint of radiographic progression-free survival (rPFS) with a 31 percent reduction in the risk of radiographic progression or death in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving ...

NCCN Gets Personal About Improving Global Cancer Care for World Cancer Day Global oncology community looks at the impact from COVID-19 on cancer care over the past year. PLYMOUTH MEETING, Pa., Feb. 4, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN )-an alliance of leading cancer centers in the United States-joins people and organizations worldwide in commemorating World Cancer Day every February 4. World Cancer Day 2021 is dedicated to the courage and achievements of peop...